This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Ucb Pharma Gmbh. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: Sabrina Gollos: Innovator in CNS Therapeutics
Introduction
Sabrina Gollos is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate GPR17 properties. With a total of 3 patents to her name, her work is paving the way for new treatments in central nervous system (CNS) diseases.
Latest Patents
Her latest patents include Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides. These patents disclose sulfonamide compounds that possess GPR17 modulating properties. They are particularly useful for treating or preventing a variety of CNS diseases, especially myelinating diseases or disorders.
Career Highlights
Sabrina Gollos is currently employed at UCB Pharma GmbH, where she continues to innovate and contribute to the pharmaceutical industry. Her research focuses on developing effective treatments for complex neurological conditions.
Collaborations
Sabrina collaborates with notable colleagues, including Michael Louis Robert Deligny and Anaïs Barré. These partnerships enhance her research efforts and contribute to the advancement of therapeutic solutions.
Conclusion
Sabrina Gollos is a key figure in the field of CNS therapeutics, with her innovative patents and collaborative spirit driving progress in medical science. Her work holds promise for improving the lives of those affected by myelinating diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile